CEO and Chairman of the Board of Valeant Pharmaceuticals International (VRX, Financial) J. Michael Pearson buys 7,000 shares of VRX on 05/07/2009 at an average price of $18.51 a share.
Valeant Pharmaceuticals International is a global publicly traded research-based specialty pharmaceutical company that discovers develops manufactures and markets a broad range of pharmaceutical products. Valeant Pharmaceuticals International has a market cap of $1.6 billion; its shares were traded at around $19.41 with a P/E ratio of 36.6 and P/S ratio of 2.4. Valeant Pharmaceuticals International had an annual average earning growth of 2.9% over the past 5 years.
VRX is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of Valeant Pharmaceuticals International by CEO:
Recent Trades of Valeant Pharmaceuticals International by CFO:
Recent Trades of Valeant Pharmaceuticals International by Directors and Officers:
Valeant Pharmaceuticals International is a global publicly traded research-based specialty pharmaceutical company that discovers develops manufactures and markets a broad range of pharmaceutical products. Valeant Pharmaceuticals International has a market cap of $1.6 billion; its shares were traded at around $19.41 with a P/E ratio of 36.6 and P/S ratio of 2.4. Valeant Pharmaceuticals International had an annual average earning growth of 2.9% over the past 5 years.
VRX is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of Valeant Pharmaceuticals International by CEO:
- Buy: CEO and Chairman of the Board J. Michael Pearson bought 7,000 shares of VRX stock on 05/07/2009 at the average price of $18.51; the price of the stock has increased by 4.86% since.
Recent Trades of Valeant Pharmaceuticals International by CFO:
- Buy: EVP & CFO Peter J Blott bought 4,750 shares of VRX stock on 03/11/2009 at the average price of $16.78; the price of the stock has increased by 15.67% since.
- Buy: EVP & CFO Peter J Blott bought 4,100 more shares of VRX stock on 11/14/2008 at the average price of $18.24; the price of the stock has increased by 6.41% since.
Recent Trades of Valeant Pharmaceuticals International by Directors and Officers:
- Buy: President Bhaskar Chaudhuri bought 1,760 shares of VRX stock on 05/04/2009 at the average price of $17.05; the price of the stock has increased by 13.84% since.
- Buy: President Bhaskar Chaudhuri bought 1,732 more shares of VRX stock on 04/27/2009 at the average price of $17.32; the price of the stock has increased by 12.07% since.
- Buy: President Bhaskar Chaudhuri bought 1,703 more shares of VRX stock on 04/20/2009 at the average price of $17.62; the price of the stock has increased by 10.16% since.
- Buy: EVP & Chief Administrative Elisa A. Karlson bought 5,322 shares of VRX stock on 03/11/2009 at the average price of $16.97; the price of the stock has increased by 14.38% since.
- Buy: Director Richard Koppes bought 1,500 shares of VRX stock on 03/06/2009 at the average price of $16.02; the price of the stock has increased by 21.16% since.
